Kymera Therapeutics (KYMR) PT Raised to $39 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: KYMR) | Delayed: 117.57 +2.73 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.84 | 52 Week High | $ | |||
| Open | $114.52 | 52 Week Low | $ | |||
| Day High | $119.68 | P/E | N/A | |||
| Day Low | $111.15 | EPS | $ | |||
| Volume | 828,869 | |||||
